Biblio

Export 676 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is Z  [Clear All Filters]
Journal Article
A. Zhu, Wu, Z., Zhong, X., Ni, J., Li, Y., Meng, J., Du, C., Zhao, X., Nakanishi, H., and Wu, S., Brazilian Green Propolis Prevents Cognitive Decline into Mild Cognitive Impairment in Elderly People Living at High Altitude., J Alzheimers Dis, vol. 63, no. 2, pp. 551-560, 2018.
A. Zhu, Wu, Z., Zhong, X., Ni, J., Li, Y., Meng, J., Du, C., Zhao, X., Nakanishi, H., and Wu, S., Brazilian Green Propolis Prevents Cognitive Decline into Mild Cognitive Impairment in Elderly People Living at High Altitude., J Alzheimers Dis, vol. 63, no. 2, pp. 551-560, 2018.
A. Zhu, Wu, Z., Zhong, X., Ni, J., Li, Y., Meng, J., Du, C., Zhao, X., Nakanishi, H., and Wu, S., Brazilian Green Propolis Prevents Cognitive Decline into Mild Cognitive Impairment in Elderly People Living at High Altitude., J Alzheimers Dis, vol. 63, no. 2, pp. 551-560, 2018.
H. - F. Wang, Wan, Y., Hao, X. - K., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Tan, L., Zhang, D. - Q., Tan, L., and Yu, J. - T., Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration., J Alzheimers Dis, vol. 52, no. 1, pp. 179-90, 2016.
H. - F. Wang, Wan, Y., Hao, X. - K., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Tan, L., Zhang, D. - Q., Tan, L., and Yu, J. - T., Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration., J Alzheimers Dis, vol. 52, no. 1, pp. 179-90, 2016.
A. - C. Schmöle, Lundt, R., Toporowski, G., Hansen, J. N., Beins, E., Halle, A., and Zimmer, A., Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology., J Alzheimers Dis, vol. 64, no. 2, pp. 379-392, 2018.
K. Ding, Tarumi, T., Zhu, D. C., Tseng, B. Y., Thomas, B. P., Turner, M., Repshas, J., Kerwin, D. R., Womack, K. B., Lu, H., C Cullum, M., and Zhang, R., Cardiorespiratory Fitness and White Matter Neuronal Fiber Integrity in Mild Cognitive Impairment., J Alzheimers Dis, vol. 61, no. 2, pp. 729-739, 2018.
K. Ding, Tarumi, T., Zhu, D. C., Tseng, B. Y., Thomas, B. P., Turner, M., Repshas, J., Kerwin, D. R., Womack, K. B., Lu, H., C Cullum, M., and Zhang, R., Cardiorespiratory Fitness and White Matter Neuronal Fiber Integrity in Mild Cognitive Impairment., J Alzheimers Dis, vol. 61, no. 2, pp. 729-739, 2018.
E. Pinner, Gruper, Y., Ben Zimra, M., Kristt, D., Laudon, M., Naor, D., and Zisapel, N., CD44 Splice Variants as Potential Players in Alzheimer's Disease Pathology., J Alzheimers Dis, vol. 58, no. 4, pp. 1137-1149, 2017.
S. J. Fan, Xian, X. H., Li, L., Yao, X. G., Hu, Y. Y., Zhang, M., and Li, W. B., Ceftriaxone Improves Cognitive Function and Upregulates GLT-1-Related Glutamate-Glutamine Cycle in APP/PS1 Mice., J Alzheimers Dis, vol. 66, no. 4, pp. 1731-1743, 2018.
A. M. Stickel, Tarraf, W., Gonzalez, K. A., Isasi, C. R., Kaplan, R., Gallo, L. C., Zeng, D., Cai, J., Pirzada, A., Daviglus, M. L., Goodman, Z. T., Schneiderman, N., and González, H. M., Central Obesity, Cardiometabolic Risk, and Cognitive Change in the Study of Latinos: Investigation of Neurocognitive Aging., J Alzheimers Dis, vol. 82, no. 3, pp. 1203-1218, 2021.
D. M. Kamara, Gangishetti, U., Gearing, M., Willis-Parker, M., Zhao, L., Hu, W. T., and Walker, L. C., Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease., J Alzheimers Dis, vol. 62, no. 4, pp. 1815-1826, 2018.
S. Chaudhary, Zhornitsky, S., Chao, H. H., van Dyck, C. H., and Li, C. - S. R., Cerebral Volumetric Correlates of Apathy in Alzheimer's Disease and Cognitively Normal Older Adults: Meta-Analysis, Label-Based Review, and Study of an Independent Cohort., J Alzheimers Dis, vol. 85, no. 3, pp. 1251-1265, 2022.
D. - W. Chen, Wang, J., Zhang, L. - L., Wang, Y. - J., and Gao, C. - Y., Cerebrospinal Fluid Amyloid-β Levels are Increased in Patients with Insomnia., J Alzheimers Dis, vol. 61, no. 2, pp. 645-651, 2018.
B. M. Bettcher, Johnson, S. C., Fitch, R., Casaletto, K. B., Heffernan, K. S., Asthana, S., Zetterberg, H., Blennow, K., Carlsson, C. M., Neuhaus, J., Bendlin, B. B., and Kramer, J. H., Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage., J Alzheimers Dis, vol. 62, no. 1, pp. 385-397, 2018.
C. B. Malpas, Saling, M. M., Velakoulis, D., Desmond, P., Hicks, R. J., Zetterberg, H., Blennow, K., and O'Brien, T. J., Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type., J Alzheimers Dis, vol. 62, no. 1, pp. 417-427, 2018.
M. Bjerke, Kern, S., Blennow, K., Zetterberg, H., Waern, M., Börjesson-Hanson, A., Östling, S., Kern, J., and Skoog, I., Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years., J Alzheimers Dis, vol. 49, no. 3, pp. 733-41, 2016.
P. Buchhave, Minthon, L., Zetterberg, H., Wallin, A. K., Blennow, K., and Hansson, O., Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia., Arch Gen Psychiatry, vol. 69, no. 1, pp. 98-106, 2012.
K. E. Melah, Lu, S. Yuan- Fu, Hoscheidt, S. M., Alexander, A. L., Adluru, N., Destiche, D. J., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., Gleason, C. E., N Dowling, M., Bratzke, L. C., Rowley, H. A., Sager, M. A., Asthana, S., Johnson, S. C., and Bendlin, B. B., Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 3, pp. 873-86, 2016.
M. Shams, Martola, J., Charidimou, A., Granberg, T., Ferreira, D., Westman, E., Wintermark, M., Iv, M., Larvie, M., Wiberg, M. Kristoffer, Kaijser, M., Forsgard, N., Zetterberg, H., Wahlund, L. - O., and Shams, S., Cerebrospinal Fluid Metals and the Association with Cerebral Small Vessel Disease., J Alzheimers Dis, vol. 78, no. 3, pp. 1229-1236, 2020.
S. Lista, Toschi, N., Baldacci, F., Zetterberg, H., Blennow, K., Kilimann, I., Teipel, S. J., Cavedo, E., Santos, A. Melo Dos, Epelbaum, S., Lamari, F., Dubois, B., Nisticò, R., Floris, R., Garaci, F., and Hampel, H., Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study., J Alzheimers Dis, vol. 59, no. 4, pp. 1327-1334, 2017.
E. van den Berg, Nilsson, J., Kersten, I., Brinkmalm, G., de Kort, A. M., Klijn, C. J. M., Schreuder, F. H. B. M., Jäkel, L., Gobom, J., Portelius, E., Zetterberg, H., Brinkmalm, A., Blennow, K., H Kuiperij, B., and Verbeek, M. M., Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease., J Alzheimers Dis, vol. 92, no. 2, pp. 467-475, 2023.
A. Morrow, Panyard, D. J., Deming, Y. K., Jonaitis, E., Dong, R., Vasiljevic, E., Betthauser, T. J., Kollmorgen, G., Suridjan, I., Bayfield, A., Van Hulle, C. A., Zetterberg, H., Blennow, K., Carlsson, C. M., Asthana, S., Johnson, S. C., and Engelman, C. D., Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation., J Alzheimers Dis, vol. 90, no. 2, pp. 667-680, 2022.
R. Kustra, Awh, C. C., Rojas-Fernandez, C., and Zanke, B., CFH and ARMS2 Polymorphisms Interact with Zinc Supplements in Cognitive Impairment in the Women's Health Initiative Hormone Trial., J Alzheimers Dis, vol. 66, no. 2, pp. 707-715, 2018.
E. Vallino Costassa, Fiorini, M., Zanusso, G., Peletto, S., Acutis, P., Baioni, E., Maurella, C., Tagliavini, F., Catania, M., Gallo, M., Faro, M. Lo, Chieppa, M. Novella, Meloni, D., D'Angelo, A., Paciello, O., Ghidoni, R., Tonoli, E., Casalone, C., and Corona, C., Characterization of Amyloid-β Deposits in Bovine Brains., J Alzheimers Dis, vol. 51, no. 3, pp. 875-87, 2016.

Pages